Wealth Enhancement Advisory Services, LLC Axsome Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 20,678 shares of AXSM stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,678
Previous 20,644
0.16%
Holding current value
$2.14 Million
Previous $2.41 Million
10.34%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AXSM
# of Institutions
405Shares Held
36.4MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$402 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$342 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$303 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$175 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$101 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.44B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...